Professional Documents
Culture Documents
Chief Content Officer Global Voices for Change Initiative Centre for African Affairs and Global Peace
To assist consumers, clinicians, purchasers, and policymakers to make informed decisions that will improve health care at both the individual and population levels.
Systematic reviews of existing evidence on original research Informs health care decisions by providing evidence on the effectiveness, benefits, and harms of treatment options Evidence is found in 2 ways:
Researchers identify existing clinical trials
Researchers conduct studies that generate new
evidence
Provides objective information to make the best possible treatment choices Includes pros and cons of treatment options Informs clinicians on the comparative efficacy of treatment for different patient subgroups Offers an important tool to help understand the facts about different treatments
Uncertainty about best practice involving treatement and technologies Translates scientific advances to clinical practice Provides usable information for clinicians and patients
Created by the Medicare Prescription Drug, Improvement, and Modernization Act (MMA)
Section 1013 authorizes AHRQ to conduct and
suppport research that focuses on comparing outcomes and effectiveness of different treatments and clinical approaches Clinical evidence is synthesized and reviewed
Research Reviews
Comparative effectivenes reviews Technical briefs
Consumers
Policymakers
Places a focus on research questions about medical care and services that:
Impose high costs on Medicare, Medicaid, or the
Childrens Health Insurance Program (CHIP) May be over- or underutilized May significantly improve prevention, treatment, or cure of diseases and conditions that impose high costs Address conditions that place a great burden on atrisk populations:
eg. Women, children,elderly, disabled
Housed at the top universities or research organizations in North America Comparative effective research and systematic reviews are conducted at EPCs
Reviews the effectiveness of medications,
devices, and other health care services Goal is to help patients, physicians, and policymakers make better treatment decisions
Identify new and emerging clinical interventions Review and synthesize current medical research Identify gaps between existing medical research and the needs of clinical practice 4. Promote and generate new scientific evidence and analytic tools 5. Train and develop clinical researchers 6. Translate and disseminate research findings to diverse stakeholders 7. Reach out to stakeholders via a citizen forum
1. 2. 3.
Develop key research questions Establish criteria for literature search Abstract relevant data Conduct analyses Synthesize and interpret results Evaluate study quality and evidence strength Identify future research needs
Questions that are most important to patients and health care decision-makers are proposed and carefully chosen
Health outcomes are given more weight than
Types of research studies that provide useful evidence defined, collected, and assessed
Greater weight given to methods that reduce
biased results
Research conducted outside EPC program and updated reports are warranted. Clinician and consumer summaries are created.
condition or disease Type of evidence supporting efficacy and safety of interventions and if reasonably well-defined patient population, interventions, and outcome measures exist Current controversy or important uncertainties Potential impact of topic, with higher ratings that address costs to patients or society Potential value of CER relative to existing information
A team of experts decide on questions that pose important issues for people with a specific condition Key questions are determined by considering Population, Intervention, Comparator, Outcome, Timing and Setting (PICOTS) Systematic reviews are conducted to identify evidence from databases such as MEDLINE, Cochrane Database of Systematic Reviews (CDSR), EMBASE, Database of Abstracts of Reviews of Effects (DARE) Draft reports of review findings available to the public for comment before it is officially published
Effectiveness trials aim to study patients likely to be offered the intervention in everyday practice
Determine importance in terms of the balance of
High
Ratings based on modified GRADE system Strength of evidence for each key clinical question graded as follows:
Consistent results have been reported in high-quality clinical trials; further research is very unlikely to change the conclusions Findings are supported, but further research could change the conclusions
Moderate
Low
Very few clinical trials are available, or existing trials are flawed Low confidence that the evidence reflects the true effect Further research is likely to change the conclusions
Evidence either is unavailable or does not permit estimation of an effect
Insufficient
Requires assessment of 4 domains: risk of bias, consistency, directness, and precision Additional domains include dose-response association, presence of confounders, and publication bias EPC investigators evaluate the strength of evidence separately for each important comparison for each key question Required criteria for assessing sufficient trial data includes determining the risk of bias, consistency, directness, and precision
Stakeholders are individuals or organizatons that have a personal or professional intereast in the topic Engaging stakeholders is a process of giving voice and involving Stakeholders in the EHC program related decision-making and research Serves the purposes or reciprocal learning and knowledge exchange to improve health outcomes
Stakeholder Roles
Clinicians Patients/Consumers Health outcomes Diagnostic/Treatment Treatment options Benefits/risks Benefits/risks Guidelines Quality of life Documentation
Is an approach where clinicians and patients communicate together using the best available evidence when faced with the task of making decisions, where patients are supported to deliberate about the possible attributes and consequences of options, to arrive at informed preferences in making a determination about the best action and which respects patient autonomy, where this is desired, ethical and legal.
Disease severity Rarity of disease Existing alternative treatments Cost (new vs existing treatment) Population affected Existing community standards for treatment Influence of future research on decisions Pharmacoeconomic analyses
prevented or treated Risks, benefits, alternatives, and uncertainties of preventive methods or treatments
Can inform decision-making by providing consolidated evidence-based data Can identify and fill knowledge gaps that cause uncertainties in clinical practice Can determine best treatment options for patient with different medical histories, circumstances, or values Can validate existing clinical practice guidelines Can transform evidence into action